CLL
Clinical trials for CLL explained in plain language.
Never miss a new study
Get alerted when new CLL trials appear
Sign up with your email to follow new studies for CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for blood cancers
Disease control CompletedThis study tested a combination of two drugs, acalabrutinib and pembrolizumab, in 161 people with different types of blood cancers like lymphoma and leukemia. The main goal was to check safety and see how well the treatment works. This is an early-stage study, so results help gui…
Matched conditions: CLL
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated May 17, 2026 08:49 UTC
-
CLL drug combo under microscope: bleeding risk checked
Disease control CompletedThis study looked at 45 people with chronic lymphocytic leukemia (CLL) who were taking the targeted drug acalabrutinib (Calquence) along with a direct oral anticoagulant (DOAC) — a type of blood thinner. The goal was to see how often major bleeding events occurred. The study was …
Matched conditions: CLL
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated May 17, 2026 08:48 UTC
-
Cholesterol drug shows promise in leukemia combo trial
Disease control CompletedThis early-phase study tested adding the cholesterol-lowering drug pitavastatin to the standard targeted therapy venetoclax for people with chronic lymphocytic leukemia (CLL) or acute myeloid leukemia (AML). The main goal was to find a safe dose and check for side effects. Only 6…
Matched conditions: CLL
Phase: PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 06, 2026 16:01 UTC